Does OCRELIZUMAB Cause Type i hypersensitivity? 5 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 5 reports of Type i hypersensitivity have been filed in association with OCRELIZUMAB (OCREVUS). This represents 0.0% of all adverse event reports for OCRELIZUMAB.
5
Reports of Type i hypersensitivity with OCRELIZUMAB
0.0%
of all OCRELIZUMAB reports
0
Deaths
0
Hospitalizations
How Dangerous Is Type i hypersensitivity From OCRELIZUMAB?
Of the 5 reports.
Is Type i hypersensitivity Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for OCRELIZUMAB. However, 5 reports have been filed with the FAERS database.
What Other Side Effects Does OCRELIZUMAB Cause?
Covid-19 (11,454)
Fatigue (5,704)
Urinary tract infection (3,618)
Headache (3,036)
Multiple sclerosis (2,609)
Asthenia (2,509)
Nasopharyngitis (2,479)
Gait disturbance (2,384)
Pneumonia (2,333)
Pain (2,327)
What Other Drugs Cause Type i hypersensitivity?
OXALIPLATIN (266)
AMOXICILLIN (260)
LEVOFLOXACIN (180)
ACETAMINOPHEN (129)
CARBOPLATIN (125)
DICLOFENAC (111)
PANTOPRAZOLE (110)
PACLITAXEL (107)
IBUPROFEN (103)
OMEPRAZOLE (98)
Which OCRELIZUMAB Alternatives Have Lower Type i hypersensitivity Risk?
OCRELIZUMAB vs OCRIPLASMIN
OCRELIZUMAB vs OCTINOXATE\OCTISALATE\ZINC
OCRELIZUMAB vs OCTINOXATE\OCTOCRYLENE
OCRELIZUMAB vs OCTREOTIDE
OCRELIZUMAB vs OCTREOTIDE\OCTREOTIDE